CollPlant Biotechnologies Ltd. - Ordinary Shares (CLGN)

4.4126
0.00 (0.00%)

Collplant Biotechnologies Ltd is a biotechnology company focused on developing innovative solutions for tissue regeneration and wound healing

The company harnesses its proprietary recombinant human collagen technology, which is designed to support the body’s natural healing processes. Collplant’s primary applications include products aimed at treating various medical conditions, including skin wounds, surgical recovery, and orthopedic injuries. By leveraging its advanced biotechnological capabilities, Collplant aims to improve patient outcomes and offer alternatives to traditional treatments in the regenerative medicine field.

SummaryNewsPress ReleasesChartHistoricalFAQ
Stratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and Organs
Stratasys Ltd. (Nasdaq: SSYS) and CollPlant Biotechnologies (Nasdaq: CLGN) today announced a joint development and commercialization agreement to collaborate on the development of a solution to bio-fabricate human tissues and organs using Stratasys’ P3 technology-based bioprinter and CollPlant’s rh-Collagen-based bioinks. The first project focuses on the development of an industrial-scale solution for CollPlant's regenerative breast implants program.
By Stratasys Ltd. · Via Business Wire · April 4, 2023
36 of the Best Ideas Companies to Present at the Fall Harvest - Best Ideas from the Buy-Side Virtual Investor Conference on October 5th - 8th, 2021
RALEIGH, NC / ACCESSWIRE / October 4, 2021 / The Fall Harvest - Best Ideas from the Buy-Side will take place on October 5th - 8th, 2021, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience. The Fall Harvest - Best Ideas from the Buy Side: VIRTUAL begins on Tuesday, October 5th, 2021, with company presentations beginning at 8:30 am Eastern Time. Presentations will be
By MicroCap Rodeo · Via AccessWire · October 4, 2021